BHC insider trading

NYSE Healthcare

Bausch Health Companies Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
579
Last 90 days
22
Buys / sells
7% / 7%
Market cap
$1.86B

About Bausch Health Companies Inc.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Company website: www.bauschhealth.com

BHC insider activity at a glance

FilingIQ has scored 579 insider transactions for BHC since Aug 9, 2018. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 38 open-market purchases and 39 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BHC insider trades is 58.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

13F funds holding BHC

Frequently asked

How many insider trades does FilingIQ track for BHC?
FilingIQ tracks 579 Form 4 insider transactions for BHC (Bausch Health Companies Inc.), covering filings from Aug 9, 2018 onwards. 22 of those were filed in the last 90 days.
Are BHC insiders net buyers or net sellers?
Across the full Form 4 history for BHC, 38 transactions (7%) were open-market purchases and 39 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BHC insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BHC in?
Bausch Health Companies Inc. (BHC) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.86B.

Methodology & sources

Every BHC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.